Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -19.33%-19.26K | -51.85%-48.97K | -249.85%-21.88K | 81.36%-109.45K | -22.74%-54.8K | 75.58%-16.14K | 89.97%-32.25K | 95.97%-6.25K | -341.39%-587.24K | -464.89%-44.65K |
| Net income from continuing operations | -123.83%-49.29K | 53.02%-26.69K | 18.19%-46.59K | 55.86%-228.6K | -12.94%-92.82K | 85.04%-22.02K | 73.82%-56.82K | 20.42%-56.95K | -246.67%-517.92K | -122.05%-82.18K |
| Operating gains losses | ---- | ---- | ---- | -7,818.39%-688.9K | ---- | ---- | ---- | ---- | ---8.7K | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | --547.11K | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --28.39K | ---- | ---- | 280.11%183.62K | --163.28K | --0 | ---- | ---- | --48.31K | --0 |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -49.94%834 | --0 |
| Change In working capital | -72.25%1.63K | -626.87%-22.28K | -51.25%24.71K | 170.46%77.33K | -64.25%16.53K | -92.75%5.88K | 102.77%4.23K | 160.18%50.7K | -847.14%-109.76K | 65.95%46.23K |
| -Change in receivables | 42.61%-427 | -144.27%-842 | -39.70%24.33K | 228.92%40.81K | 80.98%-705 | -106.01%-744 | 112.89%1.9K | 257.75%40.35K | -338.45%-31.65K | 6.63%-3.71K |
| -Change in prepaid assets | 103.23%12 | -99.85%12 | -100.59%-130 | 239.80%29.47K | -99.97%13 | -100.41%-372 | 108.00%7.78K | 139.66%22.06K | -140.67%-21.08K | 818.36%40.22K |
| -Change in payables and accrued expense | -70.75%2.05K | -293.58%-21.45K | 104.37%512 | 112.36%7.05K | 77.29%17.22K | 130.56%6.99K | 86.65%-5.45K | -284.54%-11.71K | -285.92%-57.02K | -64.61%9.71K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -19.33%-19.26K | -51.85%-48.97K | -249.85%-21.88K | 81.36%-109.45K | -22.74%-54.8K | 75.58%-16.14K | 89.97%-32.25K | 95.97%-6.25K | -341.39%-587.24K | -464.89%-44.65K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 5,163.80%31.19K | 0 | -123.89%-15.79K | 145.98%152.11K | 3,038.86%89.33K | 99.16%-616 | 94.15%-2.7K | 130.86%66.1K | -255.05%-330.86K | 105.96%2.85K |
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 112.46%23.67K | ---193.05K | ---77.03K |
| Net other investing changes | 5,163.80%31.19K | --0 | -137.22%-15.79K | 210.38%152.11K | 11.84%89.33K | 99.61%-616 | 157.93%20.97K | 275.55%42.43K | -47.88%-137.81K | 267.28%79.87K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 5,163.80%31.19K | --0 | -123.89%-15.79K | 145.98%152.11K | 3,038.86%89.33K | 99.16%-616 | 94.15%-2.7K | 130.86%66.1K | -255.05%-330.86K | 105.96%2.85K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 898.40%1.12M | 0 | |||||||
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -202.50%-102.5K | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 9,940.00%1.26M | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---29.3K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 898.40%1.12M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -29.18%167.12K | -20.24%216.09K | 20.21%253.76K | 3,428.16%211.09K | -13.34%219.23K | -39.85%235.99K | -58.95%270.94K | 3,428.16%211.09K | -95.00%5.98K | 310.45%252.98K |
| Current changes in cash | 171.19%11.93K | -40.10%-48.97K | -162.94%-37.67K | -79.20%42.67K | 182.42%34.53K | 87.98%-16.76K | 86.94%-34.95K | -90.85%59.85K | 280.35%205.11K | 24.72%-41.89K |
| End cash Position | -18.33%179.05K | -29.18%167.12K | -20.24%216.09K | 20.21%253.76K | 20.21%253.76K | -13.34%219.23K | -39.85%235.99K | -58.95%270.94K | 3,428.16%211.09K | 3,428.16%211.09K |
| Free cash from | -19.33%-19.26K | -51.85%-48.97K | -249.85%-21.88K | 85.97%-109.45K | 54.96%-54.8K | -190.34%-16.14K | 90.27%-32.25K | 98.19%-6.25K | -486.49%-780.28K | -1,439.42%-121.68K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.